Your browser doesn't support javascript.
loading
Should We Consider Including a Value for "Hope" as an Additional Benefit Within Health Technology Assessment?
Peasgood, Tessa; Mukuria, Clara; Rowen, Donna; Tsuchiya, Aki; Wailoo, Allan.
Afiliação
  • Peasgood T; Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia; School of Health and Related Research, University of Sheffield, Sheffield, England, UK. Electronic address: tessa.peasgood@unimelb.edu.au.
  • Mukuria C; School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
  • Rowen D; School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
  • Tsuchiya A; School of Health and Related Research, University of Sheffield, Sheffield, England, UK; Department of Economics, University of Sheffield, Sheffield, England, UK.
  • Wailoo A; School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
Value Health ; 25(9): 1619-1623, 2022 09.
Article em En | MEDLINE | ID: mdl-35490086
Health technology assessment (HTA) typically uses average health-related quality of life gain as its main measure of benefit used in economic evaluation. Nevertheless, there have been calls to consider novel aspects of benefit including the "value of hope," defined as a patients' potential preferences for a wider distribution of treatment benefit with a positive skew, in the hope that they will be one of the lucky ones. The value of hope may also derive from feeling hopeful as a positive mental state, which may be missing from current measures of health-related quality of life. The value attributed to feeling hopeful could be related to, or additional to, the value derived from possible risk-seeking preferences. Here, we reflect upon the strength of the case for the inclusion of the "value of hope" taking a critical look at the commonly referenced evidence for including the "value of hope" as risk-seeking preferences. We also draw attention to other conceptions of hope-as an emotion, a cognitive process, or a combination of both-and reflect upon the potential of including these broader notions of hope into HTA. The case for the inclusion of the "value of hope" based on risk-seeking preferences is weak. We suggest research questions that could give further evidence on whether hope is an important missing value from HTA.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Avaliação da Tecnologia Biomédica Tipo de estudo: Health_technology_assessment Limite: Humans Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Avaliação da Tecnologia Biomédica Tipo de estudo: Health_technology_assessment Limite: Humans Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article